CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 28, 2025	Sep. 29, 2024	Sep. 28, 2025	Sep. 29, 2024
Income Statement [Abstract]
Revenue		$ 7,990	$ 4,317	$ 20,556	$ 13,357
Cost of revenue		6,589	4,959	16,952	16,454
Gross profit (loss)		1,401	(642)	3,604	(3,097)
Operating expenses:
Research and development		28,180	24,220	82,257	102,073
Selling, general and administrative		20,194	20,744	54,613	61,176
Restructuring cost		0		0
Total operating expenses		48,374	48,625	136,870	205,056
Loss from operations		(46,973)	(49,267)	(133,266)	(208,153)
Other income (expense):
Change in fair value of common stock warrants		1,867	29,899	11,778	17,359
Gain on bargain purchase of assets		0	0	4,761	0
Interest income		2,540	2,859	7,401	9,745
Interest expense		(11,765)	(1,718)	(15,186)	(5,068)
Other income (loss), net		140	(2,217)	1,501	(1,509)
Total other income (loss), net		(7,218)	28,823	10,255	20,527
Loss before income tax expense (benefit)		(54,191)	(20,444)	(123,011)	(187,626)
Income tax expense (benefit)		(422)	2,194	(1,445)	(2,544)
Net loss		(53,769)	(22,638)	(121,566)	(185,082)
Net gain (loss) attributable to non-controlling interests		(56)	(102)	185	(306)
Net loss attributable to Enovix		$ (53,713)	$ (22,536)	$ (121,751)	$ (184,776)
Net loss per share attributable to Enovix shareholders, basic (in dollars per share)	[1]	$ (0.26)	$ (0.12)	$ (0.59)	$ (1.01)
Weighted average number of common shares outstanding, basic (in shares)	[1]	206,458,846	187,785,319	204,758,291	183,229,182
Net loss per share attributable to Enovix shareholders, diluted (in dollars per share)	[1]	$ (0.27)	$ (0.28)	$ (0.59)	$ (1.01)
Weighted-average shares outstanding used in computing net loss per share of common stock, diluted (in shares)	[1]	206,811,315	187,977,123	204,758,291	183,229,182

[1] As required by ASC 260, Earnings Per Share, the share and per share amounts for the periods presented above in the condensed consolidated financial statements have been retroactively adjusted to reflect the Warrant (as defined in Note 2 “Basis of Presentation and Summary of Significant Accounting Policies”) in July 2025. For more information on the adjusted net loss per share, please refer to Note 11 “Net Loss per Share” for more details.